NCT05917561 Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo Status RECRUITING Phase PHASE2
NCT05915182 Real-world, 52-week Prospective Study to Capture the Reasons for Switch to Triple Combination Therapy, Assess the Clinical and Patient Reported Outcomes in Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Trixeo Aerosphere™ in Routine Care Settings in Greece Status COMPLETED Phase N/A
NCT05913440 HER2-low Unresectable and/or Metastatic Breast Cancer in Russia Status COMPLETED Phase N/A
NCT05905939 HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia Status COMPLETED Phase N/A
NCT05903989 Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND) Status COMPLETED Phase N/A
NCT05903092 MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT05898412 Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya Status COMPLETED Phase N/A
NCT05892926 HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia Status COMPLETED Phase N/A
NCT05891847 Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05888857 MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. Status NOT_YET_RECRUITING Phase PHASE2
NCT05888207 A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT05887011 CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05886244 Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China Status COMPLETED Phase PHASE3
NCT05885009 Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102) Status RECRUITING Phase N/A
NCT05883644 Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05877599 A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation Status RECRUITING Phase PHASE1
NCT05876351 Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China Status COMPLETED Phase PHASE3
NCT05872958 Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study Status COMPLETED Phase PHASE1
NCT05866276 To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients Status COMPLETED Phase N/A